866-997-4948(US-Canada Toll Free)

Global Parenteral Drugs Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Jul 2019

Category :

Pharmaceutical

No. of Pages : 127 Pages

Parenteral Drug (LVP, SVP) is defined as one intended for injection through the skin or other external boundary tissue, rather than through the alimentary canal, so that active substances they contain are administered, using gravity or force, directly into a blood vessel, organ, tissue, or lesion. They are infused when administered intravenously (IV), or injected when administered intramuscularly (IM), or subcutaneously into the human body. A large volume parenteral (LVP) is a unit dose container of greater than 100ml that is terminally sterilized by heat. Small volume parenteral (SVP) is a "catch-all" for all non-LVP parenterals products except biologicals.
Parenteral drugs, whether a small-molecule or biologic-based drug substance, has increased their share of the overall drug market although solid-dosage products still prevail.
The global Parenteral Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Parenteral Drugs market based on company, product type, end user and key regions.

This report studies the global market size of Parenteral Drugs in key regions like North America, Europe, China and Japan, focuses on the consumption of Parenteral Drugs in these regions.
This research report categorizes the global Parenteral Drugs market by top players/brands, region, type and end user. This report also studies the global Parenteral Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Ostuka Pharmaceutical
Teva Pharmaceutical Industries
Kelun Pharma
Cook Pharmica
Patheon
BAG Healthcare
Beximco Pharma
Baxter Healthcare Corporation
B. Braun
Fresenius
Albert David
BML Parenteral Drugs
Pfizer (Hospira)
Pisa
Ozon Pharmaceuticals Ltd
Aspen Holdings
PSI Ltd
Wintac Limited
AXA Parenterals Ltd
Acebright
Southwest Pharmaceutical
Abbott

Parenteral Drugs market size by Type
LVP Drug
SVP Drug

100ml
100ml

Parenteral Drugs market size by Applications
Hospitals
Medical Centers
Others

Market size by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Parenteral Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Parenteral Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Parenteral Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Parenteral Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Parenteral Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Parenteral Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Parenteral Drugs Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Parenteral Drugs Market Size Growth Rate by Type
1.4.2 LVP Drug
1.4.3 SVP Drug
1.5 Market by Application
1.5.1 Global Parenteral Drugs Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Medical Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Parenteral Drugs Market Size
2.1.1 Global Parenteral Drugs Revenue 2014-2025
2.1.2 Global Parenteral Drugs Sales 2014-2025
2.2 Parenteral Drugs Growth Rate by Regions
2.2.1 Global Parenteral Drugs Sales by Regions
2.2.2 Global Parenteral Drugs Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Parenteral Drugs Sales by Manufacturers
3.1.1 Parenteral Drugs Sales by Manufacturers
3.1.2 Parenteral Drugs Sales Market Share by Manufacturers
3.2 Parenteral Drugs Revenue by Manufacturers
3.2.1 Parenteral Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Parenteral Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Parenteral Drugs Price by Manufacturers
3.4 Parenteral Drugs Manufacturing Base Distribution, Product Types
3.4.1 Parenteral Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Parenteral Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Parenteral Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Parenteral Drugs Sales by Type
4.2 Global Parenteral Drugs Revenue by Type
4.3 Parenteral Drugs Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Parenteral Drugs Breakdown Data by Application

6 North America
6.1 North America Parenteral Drugs by Country
6.1.1 North America Parenteral Drugs Sales by Country
6.1.2 North America Parenteral Drugs Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Parenteral Drugs by Type
6.3 North America Parenteral Drugs by Application

7 Europe
7.1 Europe Parenteral Drugs by Country
7.1.1 Europe Parenteral Drugs Sales by Country
7.1.2 Europe Parenteral Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Parenteral Drugs by Type
7.3 Europe Parenteral Drugs by Application

8 Asia Pacific
8.1 Asia Pacific Parenteral Drugs by Region
8.1.1 Asia Pacific Parenteral Drugs Sales by Region
8.1.2 Asia Pacific Parenteral Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Thailand
8.1.10 Malaysia
8.1.11 Philippines
8.1.12 Vietnam
8.2 Asia Pacific Parenteral Drugs by Type
8.3 Asia Pacific Parenteral Drugs by Application

9 Central & South America
9.1 Central & South America Parenteral Drugs by Country
9.1.1 Central & South America Parenteral Drugs Sales by Country
9.1.2 Central & South America Parenteral Drugs Revenue by Country
9.1.3 Brazil
9.2 Central & South America Parenteral Drugs by Type
9.3 Central & South America Parenteral Drugs by Application

10 Middle East and Africa
10.1 Middle East and Africa Parenteral Drugs by Country
10.1.1 Middle East and Africa Parenteral Drugs Sales by Country
10.1.2 Middle East and Africa Parenteral Drugs Revenue by Country
10.1.3 Turkey
10.1.4 GCC Countries
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Parenteral Drugs by Type
10.3 Middle East and Africa Parenteral Drugs by Application

11 Company Profiles
11.1 Ostuka Pharmaceutical
11.1.1 Ostuka Pharmaceutical Company Details
11.1.2 Company Business Overview
11.1.3 Ostuka Pharmaceutical Parenteral Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Ostuka Pharmaceutical Parenteral Drugs Products Offered
11.1.5 Ostuka Pharmaceutical Recent Development
11.2 Teva Pharmaceutical Industries
11.2.1 Teva Pharmaceutical Industries Company Details
11.2.2 Company Business Overview
11.2.3 Teva Pharmaceutical Industries Parenteral Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Teva Pharmaceutical Industries Parenteral Drugs Products Offered
11.2.5 Teva Pharmaceutical Industries Recent Development
11.3 Kelun Pharma
11.3.1 Kelun Pharma Company Details
11.3.2 Company Business Overview
11.3.3 Kelun Pharma Parenteral Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Kelun Pharma Parenteral Drugs Products Offered
11.3.5 Kelun Pharma Recent Development
11.4 Cook Pharmica
11.4.1 Cook Pharmica Company Details
11.4.2 Company Business Overview
11.4.3 Cook Pharmica Parenteral Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Cook Pharmica Parenteral Drugs Products Offered
11.4.5 Cook Pharmica Recent Development
11.5 Patheon
11.5.1 Patheon Company Details
11.5.2 Company Business Overview
11.5.3 Patheon Parenteral Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Patheon Parenteral Drugs Products Offered
11.5.5 Patheon Recent Development
11.6 BAG Healthcare
11.6.1 BAG Healthcare Company Details
11.6.2 Company Business Overview
11.6.3 BAG Healthcare Parenteral Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 BAG Healthcare Parenteral Drugs Products Offered
11.6.5 BAG Healthcare Recent Development
11.7 Beximco Pharma
11.7.1 Beximco Pharma Company Details
11.7.2 Company Business Overview
11.7.3 Beximco Pharma Parenteral Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Beximco Pharma Parenteral Drugs Products Offered
11.7.5 Beximco Pharma Recent Development
11.8 Baxter Healthcare Corporation
11.8.1 Baxter Healthcare Corporation Company Details
11.8.2 Company Business Overview
11.8.3 Baxter Healthcare Corporation Parenteral Drugs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Baxter Healthcare Corporation Parenteral Drugs Products Offered
11.8.5 Baxter Healthcare Corporation Recent Development
11.9 B. Braun
11.9.1 B. Braun Company Details
11.9.2 Company Business Overview
11.9.3 B. Braun Parenteral Drugs Sales, Revenue and Gross Margin (2014-2019)
11.9.4 B. Braun Parenteral Drugs Products Offered
11.9.5 B. Braun Recent Development
11.10 Fresenius
11.10.1 Fresenius Company Details
11.10.2 Company Business Overview
11.10.3 Fresenius Parenteral Drugs Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Fresenius Parenteral Drugs Products Offered
11.10.5 Fresenius Recent Development
11.11 Albert David
11.12 BML Parenteral Drugs
11.13 Pfizer (Hospira)
11.14 Pisa
11.15 Ozon Pharmaceuticals Ltd
11.16 Aspen Holdings
11.17 PSI Ltd
11.18 Wintac Limited
11.19 AXA Parenterals Ltd
11.20 Acebright
11.21 Southwest Pharmaceutical
11.22 Abbott

12 Future Forecast
12.1 Parenteral Drugs Market Forecast by Regions
12.1.1 Global Parenteral Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Parenteral Drugs Revenue Forecast by Regions 2019-2025
12.2 Parenteral Drugs Market Forecast by Type
12.2.1 Global Parenteral Drugs Sales Forecast by Type 2019-2025
12.2.2 Global Parenteral Drugs Revenue Forecast by Type 2019-2025
12.3 Parenteral Drugs Market Forecast by Application
12.4 North America Parenteral Drugs Forecast
12.5 Europe Parenteral Drugs Forecast
12.6 Asia Pacific Parenteral Drugs Forecast
12.7 Central & South America Parenteral Drugs Forecast
12.8 Middle East and Africa Parenteral Drugs Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Parenteral Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Table

List of Tables and Figures

Figure Parenteral Drugs Product Picture
Table Parenteral Drugs Market Segments
Table Key Manufacturers Parenteral Drugs Covered
Table Global Parenteral Drugs Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
Figure Global Parenteral Drugs Sales Market Share by Type in 2018 & 2025
Figure LVP Drug Product Picture
Table Major Manufacturers of LVP Drug
Figure SVP Drug Product Picture
Table Major Manufacturers of SVP Drug
Table Global Parenteral Drugs Market Size Growth Rate by Application 2019-2025 (K Units)
Figure Global Parenteral Drugs 4900 Sales Market Share by Application in 2018
Figure Hospitals
Figure Medical Centers
Figure Others
Figure Parenteral Drugs Report Years Considered
Figure Global Parenteral Drugs Market Size 2014-2025 (Million US$)
Figure Global Parenteral Drugs Sales 2014-2025 (K Units)
Table Global Parenteral Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Parenteral Drugs Sales by Regions 2014-2019 (K Units)
Table Global Parenteral Drugs Sales Market Share by Regions 2014-2019
Figure Global Parenteral Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Parenteral Drugs Sales Market Share by Regions
Table Global Parenteral Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Parenteral Drugs Revenue Market Share by Regions 2014-2019
Figure Global Parenteral Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Parenteral Drugs Revenue Market Share by Regions
Table Global Parenteral Drugs Sales by Manufacturers (2014-2019) (K Units)
Table Global Parenteral Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Parenteral Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Parenteral Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Parenteral Drugs Revenue Share by Manufacturers (2014-2019)
Figure Parenteral Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Parenteral Drugs Price (2014-2019) (USD/Unit)
Table Parenteral Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Parenteral Drugs Product Type
Table Date of International Manufacturers Enter into Parenteral Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Parenteral Drugs Sales by Type (2014-2019) (K Units)
Table Global Parenteral Drugs Sales Share by Type (2014-2019)
Figure Global Parenteral Drugs Sales Market Share by Type (2014-2019)
Figure Global Parenteral Drugs Sales Market Share by Type in 2018
Table Global Parenteral Drugs Revenue by Type (2014-2019) (Million US$)
Table Global Parenteral Drugs Revenue Share by Type (2014-2019)
Figure Global Parenteral Drugs Revenue Market Share by Type (2014-2019)
Figure Global Parenteral Drugs Revenue Market Share by Type in 2018
Table Parenteral Drugs Price by Type 2014-2019 (USD/Unit)
Table Global Parenteral Drugs Sales by Application (2014-2019) (K Units)
Table Global Parenteral Drugs Sales Share by Application (2014-2019)
Figure Global Sales Parenteral Drugs Market Share by Application (2014-2019)
Figure Global Sales Parenteral Drugs Market Share by Application in 2018
Figure North America Parenteral Drugs Sales Growth Rate 2014-2019 (K Units)
Figure North America Parenteral Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Parenteral Drugs Sales by Country (2014-2019) (K Units)
Table North America Parenteral Drugs Sales Market Share by Country (2014-2019)
Figure 2018 North America Parenteral Drugs Sales Market Share by Country
Table North America Parenteral Drugs Revenue by Country (2014-2019) (Million US$)
Table North America Parenteral Drugs Revenue Market Share by Country (2014-2019)
Figure 2018 North America Parenteral Drugs Revenue Market Share by Country
Figure United States Parenteral Drugs Sales Growth Rate (2014-2019) (K Units)
Figure United States Parenteral Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Canada Parenteral Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Canada Parenteral Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Parenteral Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Parenteral Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Parenteral Drugs Sales by Type (2014-2019) (K Units)
Table North America Parenteral Drugs Sales Market Share by Type (2014-2019)
Figure 2018 North America Parenteral Drugs Market Share by Type
Table North America Parenteral Drugs Sales by Application (2014-2019) (K Units)
Table North America Parenteral Drugs Sales Market Share by Application (2014-2019)
Figure 2018 North America Parenteral Drugs Market Share by Application
Figure Europe Parenteral Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Europe Parenteral Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Parenteral Drugs Sales by Country (2014-2019) (K Units)
Table Europe Parenteral Drugs Sales Market Share by Country (2014-2019)
Figure 2018 Europe Parenteral Drugs Sales Market Share by Country
Table Europe Parenteral Drugs Revenue by Country (2014-2019) (Million US$)
Table Europe Parenteral Drugs Revenue Market Share by Country (2014-2019)
Figure 2018 Europe Parenteral Drugs Revenue Market Share by Country
Figure Germany Parenteral Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Germany Parenteral Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Parenteral Drugs Sales Growth Rate (2014-2019) (K Units)
Figure France Parenteral Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Parenteral Drugs Sales Growth Rate (2014-2019) (K Units)
Figure UK Parenteral Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Parenteral Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Italy Parenteral Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Parenteral Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Russia Parenteral Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Parenteral Drugs Sales by Type (2014-2019) (K Units)
Table Europe Parenteral Drugs Sales Market Share by Type (2014-2019)
Figure 2018 Europe Parenteral Drugs Market Share by Type
Table Europe Parenteral Drugs Sales by Application (2014-2019) (K Units)
Table Europe Parenteral Drugs Sales Market Share by Application (2014-2019)
Figure 2018 Europe Parenteral Drugs Market Share by Application
Figure Asia Pacific Parenteral Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Parenteral Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Parenteral Drugs Sales by Region (2014-2019) (K Units)
Table Asia Pacific Parenteral Drugs Sales Market Share by Region (2014-2019)
Figure 2018 Asia Pacific Parenteral Drugs Sales Market Share by Region
Table Asia Pacific Parenteral Drugs Revenue by Region (2014-2019) (Million US$)
Table Asia Pacific Parenteral Drugs Revenue Market Share by Region (2014-2019)
Figure 2018 Asia Pacific Parenteral Drugs Revenue Market Share by Country
Figure China Parenteral Drugs Sales Growth Rate (2014-2019) (K Units)
Figure China Parenteral Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Parenteral Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Japan Parenteral Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Korea Parenteral Drugs Sales Growth Rate (2014-2019) (K Units)
Figure South Korea Parenteral Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Parenteral Drugs Sales Growth Rate (2014-2019) (K Units)
Figure India Parenteral Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Parenteral Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Australia Parenteral Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Parenteral Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Parenteral Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Parenteral Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Parenteral Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Parenteral Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Parenteral Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Parenteral Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Parenteral Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Parenteral Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Parenteral Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Parenteral Drugs Sales by Type (2014-2019) (K Units)
Table Asia Pacific Parenteral Drugs Sales Market Share by Type (2014-2019)
Figure 2018 Asia Pacific Parenteral Drugs Market Share by Type
Table Asia Pacific Parenteral Drugs Sales by Application (2014-2019) (K Units)
Table Asia Pacific Parenteral Drugs Sales Market Share by Application (2014-2019)
Figure 2018 Asia Pacific Parenteral Drugs Market Share by Application
Figure Central & South America Parenteral Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Parenteral Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Parenteral Drugs Sales by Country (2014-2019) (K Units)
Table Central & South America Parenteral Drugs Sales Market Share by Country (2014-2019)
Figure 2018 Central & South America Parenteral Drugs Sales Market Share by Country
Table Central & South America Parenteral Drugs Revenue by Country (2014-2019) (Million US$)
Table Central & South America Parenteral Drugs Revenue Market Share by Country (2014-2019)
Figure 2018 Central & South America Parenteral Drugs Revenue Market Share by Country
Figure Brazil Parenteral Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Parenteral Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Parenteral Drugs Sales by Type (2014-2019) (K Units)
Table Central & South America Parenteral Drugs Sales Market Share by Type (2014-2019)
Figure 2018 Central & South America Parenteral Drugs Market Share by Type
Table Central & South America Parenteral Drugs Sales by Application (2014-2019) (K Units)
Table Central & South America Parenteral Drugs Sales Market Share by Application (2014-2019)
Figure 2018 Central & South America Parenteral Drugs Market Share by Application
Figure Middle East and Africa Parenteral Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Parenteral Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Parenteral Drugs Sales by Country (2014-2019) (K Units)
Table Middle East and Africa Parenteral Drugs Sales Market Share by Country (2014-2019)
Figure 2018 Middle East and Africa Parenteral Drugs Sales Market Share by Country
Table Middle East and Africa Parenteral Drugs Revenue by Country (2014-2019) (Million US$)
Table Middle East and Africa Parenteral Drugs Revenue Market Share by Country (2014-2019)
Figure 2018 Middle East and Africa Parenteral Drugs Revenue Market Share by Country
Figure Turkey Parenteral Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Parenteral Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure GCC Countries Parenteral Drugs Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Parenteral Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Parenteral Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Parenteral Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Parenteral Drugs Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Parenteral Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Parenteral Drugs Sales by Type (2014-2019) (K Units)
Table Middle East and Africa Parenteral Drugs Sales Market Share by Type (2014-2019)
Figure 2018 Middle East and Africa Parenteral Drugs Market Share by Type
Table Middle East and Africa Parenteral Drugs Sales by Application (2014-2019) (K Units)
Table Middle East and Africa Parenteral Drugs Sales Market Share by Application (2014-2019)
Figure 2018 Middle East and Africa Parenteral Drugs Market Share by Application
Table Ostuka Pharmaceutical Company Details
Table Ostuka Pharmaceutical Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Ostuka Pharmaceutical Recent Development

Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Industries Recent Development

Table Kelun Pharma Company Details
Table Kelun Pharma Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Kelun Pharma Recent Development

Table Cook Pharmica Company Details
Table Cook Pharmica Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Cook Pharmica Recent Development

Table Patheon Company Details
Table Patheon Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Patheon Recent Development

Table BAG Healthcare Company Details
Table BAG Healthcare Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table BAG Healthcare Recent Development

Table Beximco Pharma Company Details
Table Beximco Pharma Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Beximco Pharma Recent Development

Table Baxter Healthcare Corporation Company Details
Table Baxter Healthcare Corporation Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Baxter Healthcare Corporation Recent Development

Table B. Braun Company Details
Table B. Braun Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table B. Braun Recent Development

Table Fresenius Company Details
Table Fresenius Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Fresenius Recent Development

Table Albert David Company Details
Table BML Parenteral Drugs Company Details
Table Pfizer (Hospira) Company Details
Table Pisa Company Details
Table Ozon Pharmaceuticals Ltd Company Details
Table Aspen Holdings Company Details
Table PSI Ltd Company Details
Table Wintac Limited Company Details
Table AXA Parenterals Ltd Company Details
Table Acebright Company Details
Table Southwest Pharmaceutical Company Details
Table Abbott Company Details
Table Global Parenteral Drugs Sales Forecast by Regions 2019-2025 (K Units)
Table Global Parenteral Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Parenteral Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Parenteral Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Parenteral Drugs Sales Forecast by Type 2019-2025 (K Units)
Table Global Parenteral Drugs Sales Market Share Forecast by Type 2019-2025
Table Global Parenteral Drugs Revenue Forecast by Type 2019-2025 (Million US$)
Table Global Parenteral Drugs Revenue Market Share Forecast by Type 2019-2025
Table Global Parenteral Drugs Sales Forecast by Application 2019-2025 (K Units)
Table Global Parenteral Drugs Sales Market Share Forecast by Application 2019-2025
Figure North America Parenteral Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Parenteral Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Parenteral Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Parenteral Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Parenteral Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Parenteral Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Parenteral Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Parenteral Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Parenteral Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Parenteral Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Key Opportunities and Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Table Market Risks
Figure Porter's Five Forces Analysis
Table Parenteral Drugs Value Chain
Table Parenteral Drugs Customers List
Figure Channels of Distribution
Table Parenteral Drugs Distributors List
Figure Distributors Profiles
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Key Executives Interviewed
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *